TORL BioTherapeutics
PrivateLast Round
Series C
10/7/2025
Total Funding Raised
$412M
Momentum Score
25 /100
Company Overview
TORL BioTherapeutics is a biopharmaceutical company specializing in the development of antibody-drug conjugates (ADCs) and other biologics by leveraging target identification and early discovery to create proprietary drugs with optimized profiles through innovative licensing agreements.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TORL BioTherapeutics Comps
Public and private peers based on sector, stage, and business model.
TORL BioTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | 10/7/2025 | ||||
| Series B Extension | 4/10/2024 | ||||
| Series B | 4/13/2023 |
Key People
Founding team and executive leadership
TORL BioTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B Extension |
| Vertex Ventures HC | Series B, Series B Extension |
| Perceptive Advisors | Series B Extension |
| Xontogeny | Series B, Series B Extension |
| TD Securities | Series B |
| Deep Track Capital | Series B, Series B Extension |
| Avidity Partners | Series B Extension |
TORL BioTherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TORL BioTherapeutics's valuation, stock price, and market status.
